Literature DB >> 23991289

A role of indacaterol in chronic obstructive pulmonary disease management: a turning point or crossroads?

Gregory J Feldman1, Anton Edin.   

Abstract

Entities:  

Year:  2013        PMID： 23991289      PMCID： PMC3755696          DOI： 10.3978/j.issn.2072-1439.2013.07.24

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  16 in total

1.  Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.

Authors:  Donald A Mahler; Anthony D'Urzo; Eric D Bateman; Serir A Ozkan; Tracy White; Clare Peckitt; Cheryl Lassen; Benjamin Kramer
Journal:  Thorax       Date:  2012-04-27       Impact factor: 9.139

2.  Gender and chronic obstructive pulmonary disease: why it matters.

Authors:  Meilan K Han; Dirkje Postma; David M Mannino; Nicholas D Giardino; Sonia Buist; Jeffrey L Curtis; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-08-02       Impact factor: 21.405

3.  One hundred years of chronic obstructive pulmonary disease.

Authors:  Alfred P Fishman
Journal:  Am J Respir Crit Care Med       Date:  2005-05-01       Impact factor: 21.405

4.  Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use.

Authors:  Marc Decramer; Ronald Dahl; Oliver Kornmann; Stephanie Korn; David Lawrence; Danny McBryan
Journal:  Respir Med       Date:  2012-12-06       Impact factor: 3.415

Review 5.  Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol.

Authors:  Gregory J Feldman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-02-14

6.  Sustained effects of integrated COPD management on health status and exercise capacity in primary care patients.

Authors:  Annemarije L Kruis; Joan van Adrichem; Magda R Erkelens; Huub Scheepers; Hans In 't Veen; Jean Wm Muris; Niels H Chavannes
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-11-25

7.  Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled data.

Authors:  Eugene R Bleecker; Thomas Siler; Roger Owen; Benjamin Kramer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-08-18

Review 8.  Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.

Authors:  Marcos Ribeiro; Kenneth R Chapman
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-03-05

9.  Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.

Authors:  Douglas W Mapel; Anand A Dalal; Christopher M Blanchette; Hans Petersen; Gary T Ferguson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-11-09

10.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.